EIGR licenses BMY’s IFN Lambda for undisclosed (presumably small) price: http://finance.yahoo.com/news/eiger-biopharmaceuticals-announces-license-worldwide-203000440.html EIGR is the result of a recent reverse merger with CLDN (#msg-121359837).